Clinical Trials in Pölten, Austria
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Advanced Melanoma
Immunocore Ltd680 enrolled211 locationsNCT06112314
Recruiting
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System
Coronary Artery Disease
Elixir Medical Corporation5,000 enrolled17 locationsNCT06074549